RXi Pharmaceuticals Corporation (OTCBB: RXII.OB) today announced the appointment of Dr. Jeannette Graf and Dr. Leroy Young to its Scientific Advisory Board. The addition of these two highly esteemed clinicians provides RXi with invaluable experience and clinical research expertise that are key to the ongoing development of RXI-109. RXI-109 is a self-delivering RNAi compound (sd-rxRNA®) developed by RXi for the reduction of dermal scarring in planned surgeries. RXI-109 entered into a Phase 1 clinical study in June 2012. Dr. Jeannette Graf is a board certified, clinical and research dermatologist with a private practice in Great Neck, NY. She is Assistant Clinical Professor of Dermatology at the Mount Sinai School of Medicine in New York, where last year she received the “Teacher of the Year” award from the Department of Dermatology. In addition to her private practice and her academic activities, Dr. Graf is also an accomplished product developer, who has created her own skin care line based on her continuing research on natural active ingredients and deep scientific understanding of the aging processes that take place in the skin. She has also contributed to many publications as well as books on this subject, including her best seller Stop Aging, Start Living. In addition, Dr. Graf has made multiple television and news appearances on national news and cable programs including: The Dr. Oz Show, Fox And Friends, MSNBC, The View, Inside Edition, Focus On Women, CBS Early Show, Good Morning America, Mike and Juliet and Sirius Radio. One of the most widely quoted dermatologists in the country, Dr. Graf is frequently quoted in national print and online magazines and newspapers including: Allure, Self, Glamour, InStyle, Prevention, Health, Women’s Health, Redbook, Ladies’ Home Journal, Good Housekeeping, O the Oprah Magazine, Essence, Cosmopolitan, Family Circle and The New York Times. Dr. Graf did a residency in pediatrics at Schneider’s Children’s Hospital in New York, followed by 2 years as a Research Fellow at the National Institutes of Health in Bethesda where she received an award for Outstanding Achievement and obtained a patent on peptides in 1987, and by a residency in dermatology at the New York University Medical Center, which she completed in 1990.